Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
- 1 April 1999
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 17 (4) , 343-348
- https://doi.org/10.1038/7895
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in miceGene Therapy, 1998
- Regional Suppression of Tumor Growth byIn VivoTransfer of a cDNA Encoding a Secreted Form of the Extracellular Domain of theflt-1Vascular Endothelial Growth Factor ReceptorHuman Gene Therapy, 1998
- Systemic Effect of Human Growth Hormone after Intramuscular Injection of a Single Dose of a Muscle-Specific Gene MedicineHuman Gene Therapy, 1998
- Expression of Biologically Active Human Insulin-like Growth Factor-I Following Intramuscular Injection of a Formulated Plasmid in RatsHuman Gene Therapy, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Plasmid DNA Is Superior to Viral Vectors for Direct Gene Transfer into Adult Mouse Skeletal MuscleHuman Gene Therapy, 1993
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990
- Model Predicting Survival in Stage I Melanoma Based on Tumor ProgressionJNCI Journal of the National Cancer Institute, 1989